Say what you will about the benefits of clean energy or the costs of pollution, the jury has returned an ambiguous verdict on the greening of the commercial real-estate market.? The niche has become mainstream. ?Anyone who says green buildings, which are certified by third-party verifiers as demonstrating superior environmental performance and resource efficiency, are ?boutique? has not been paying attention.
The commercial buildings sector boasts the most explosive growth in green building. In 2010, a third of all new commercial construction was green, amounting to a $54 billion market for commercial green buildings. By 2015, green buildings in the commercial sector are expected to triple, accounting for $120 billion to $145 billion in new construction and $14 billion to $18 billion in major retrofit and renovation projects.
But not all commercial buildings are the same. For all practical purposes, there are three classes of commercial buildings ? Class A, Class B and Class C. These classifications are commonly used as a proxy for a building?s ability to attract high-value tenants.
While there is no standard definition for what qualifies as Class A, Class B and Class C commercial buildings, the Building Owners and Managers Association suggests considering the following criteria when classifying commercial buildings:
Class A: Most prestigious buildings competing for premier office users with rents above average for the area. Buildings have high quality standard finishes, state of the art systems, exceptional accessibility and a definite market presence.
Class B: Buildings competing for a wide range of users with rents in the average range for the area. Building finishes are fair to good for the area. Building finishes are fair to good for the area and systems are adequate, but the building does not compete with Class A at the same price.
Class C: Buildings competing for tenants requiring functional space at rents below the average for the area.
In other words, Class A buildings are the most desirable and Class C buildings are the least desirable from the typical tenant?s perspective. Greater desirability means more money. It turns out Class A is where the green paradigm has achieved the deepest penetration.
?Green building is fundamentally altering real estate market dynamics ? the nature of the product demanded by tenants, constructed by developers, required by governments and favored by capital providers,? according to RREEF Research. ?The upshot will be a redefinition of what constitutes Class A properties and even institutional-quality real estate.?
The predicted ?upshot? is rapidly becoming a reality in Manhattan?s commercial real-estate markets, which is dominated by Class A properties. In Manhattan, Class A office buildings account for 61% of the total market. Class B buildings make up 26% of the market and Class C accounts for the remaining 13%, according to Cushman & Wakefield.
While stricter government regulation may ultimately make green buildings the de-facto standard for new and renovated buildings in the future, tenant demand is the primary reason why green buildings are becoming mainstream in today?s Class A commercial real-estate market.
?At Hines, we specialize in Class A space, and we?ve reached the point where clients don?t think it?s Class A unless it?s green,? said Jerry Lea, the Executive Vice President of the real-estate investment and management firm.
Many tenants are willing to pay a premium for space in green buildings because of the lower operating costs, higher worker productivity and reputational benefits associated with the superior environmental performance of green buildings.
If the past presages the future, today?s green buildings market is chump change compared to the opportunity likely to come down the pike over the next decade. To put the scale in perspective, in 1995, the total floorspace of U.S. commercial buildings ? 58.8 billion square feet of floorspace ? exceeded the total area of the State of Delaware and amounted to more than 200 square feet for every U.S. resident.
[ [ [['A JetBlue flight from New York to Las Vegas', 3]], 'http://yhoo.it/GV9zpj', '[Related: View photos of the JetBlue plane in Amarillo]', ' ', '630', ' ', ' ', ], [ [['Afghan security forces and police killed three', 3]], 'http://yhoo.it/H9BcJE', '[Related: Bales\' wife on his alleged shooting: \'He would not do that\']', ' ', '630', ' ', ' ', ], [ [['looking for fireworks between the opposing camps', 16]], 'http://yhoo.it/GSvEsj', '[RELATED:\?It?s going to be a circus\?: Activists begin protests outside Supreme Court]', ' ', '630', ' ', ' ', ], [ [['entirely respectable way to put off the searing constitutional controversy', 8]], 'http://yhoo.it/GE6jSh', '[RELATED: Obama\?s health care law passed 2 years ago, but where are we now\?]', ' ', '630', ' ', ' ', ], [ [['Witnesses said the gunman pulled up on a black scooter', 7]], 'http://yhoo.it/GzwOIW', '[Related: New York police tighten security at Jewish sites]', ' ', '630', ' ', ' ', ], [ [['test Zimmerman for alcohol or drugs', 11]], 'http://yhoo.it/Gzn6VF', '[Related: White House says Trayvon Martin is local issue]', ' ', '630', ' ', ' ', ], [ [['Trayvon Martin decked the Neighborhood', 7]], 'http://yhoo.it/GUovUP', 'Click image to see more photos', 'http://l.yimg.com/a/p/us/news/editorial/2/61/261d2c36bccf0971c2734a4d4398aa5a.jpeg', '512', ' ', 'AP/David Goldman', ], [ [['Can you create commerce in order to regulate it', 9]], 'http://yhoo.it/GSgtu8', 'Click image to see more photos', 'http://l.yimg.com/a/p/us/news/editorial/7/78/778e2416573870cd705774e92403447d.jpeg', '630', ' ', 'AP/Charles Dharapak', ], [ [['associated with such a small earthquake', 4]], 'http://yhoo.it/GTco9z', 'Click image to see more photos', 'http://l.yimg.com/a/p/us/news/editorial/0/b4/0b493c1a47b6e3f97f8f48a2b251d7d4.jpeg', '630', ' ', 'AP Photo/Carrie Antlfinger', ], [ [['Fox News host Geraldo Rivera sparked outrage', 3]], 'http://yhoo.it/GKMVTk', 'Click image to see more photos', 'http://l.yimg.com/a/p/us/news/editorial/2/7c/27c7367bc512d233ae1790b320a5e92c.jpeg', '630', ' ', 'AP Photo/John Minchillo', ], [ [['The charges signed against Bales include', 1]], 'http://yhoo.it/wZT5zV', 'Click image to see more photos', 'http://l.yimg.com/a/p/us/news/editorial/7/a0/7a07c51b2aa0f39b1a23355046d13870.jpeg', '512', ' ', 'AP Photo/DVIDS\, Spc\. Ryan Hallock\, File', ], [ [['George Zimmerman, if I had a son', 6]], 'http://news.yahoo.com/photos/thousands-protest-fla-teen-death-1332387124-slideshow/', 'Click image to see more photos', 'http://l.yimg.com/os/152/2012/03/22/d761a49f3fcc99080a0f6a70670053cd-jpg_150905.jpg', '500', ' ', 'AP Photo/John Minchillo', ], [ [['Mohamed Merah', 10], ['prosecutor Francois Molins', 5]], 'http://news.yahoo.com/photos/four-dead-in-french-jewish-school-shooting-1332173151-slideshow', 'Click image to see more photos', 'http://l.yimg.com/cv/ip/ap/default/120321/2012_03_21t151508z_425380421_gm1e83l1sqs01_rtrmadp_3_france_shootings_raid.jpg', '630', ' ', 'REUTERS/Jean-Paul Pelissier', ], [ [['Shortly after he wrapped up his victory remarks', 2]], 'http://news.yahoo.com/photos/4-straight-romney-wins-washington-gop-caucus-1330835515-slideshow/', 'Click image to see more photos', 'http://l.yimg.com/a/p/us/news/editorial/3/e9/3e9b0082c3c3111dcc19e3527ae94cc7.jpeg', '500', ' ', 'AP Photo/Steven Senne', ], [ [['best understands the problems of average Americans', 2]], 'http://news.yahoo.com/photos/4-straight-romney-wins-washington-gop-caucus-1330835515-slideshow/', 'Click image to see more photos', 'http://l.yimg.com/a/p/us/news/editorial/3/e9/3e9b0082c3c3111dcc19e3527ae94cc7.jpeg', '500', ' ', 'AP Photo/Steven Senne', ], [ [['Group for Historic Aircraft Recovery', 7]], 'http://yhoo.it/GB2RVy', 'Click image to see more photos', 'http://l.yimg.com/os/152/2012/03/20/photo-1332257995646-4-0-jpg_171722.jpg', '630', ' ', 'AFP', ], [ [['xxxxxxxxxxxx', 11]], 'http://news.yahoo.com/photos/russian-grannies-win-bid-to-sing-at-eurovision-1331223625-slideshow/', 'Click image to see more photos', 'http://l.yimg.com/a/p/us/news/editorial/1/56/156d92f2760dcd3e75bcd649a8b85fcf.jpeg', '500', ' ', 'AP', ] ]
[ [ [['measure all but certain to fail in the face of bipartisan', 4]], '28771014', '0' ], [ [['matter what you do in this case', 5]], '28759848', '0' ], [ [['presume laws are constitutional', 7]], '28747556', '0' ], [ [['has destroyed 15 to 25 houses', 7]], '28744868', '0' ], [ [['short answer is yes', 7]], '28746030', '0' ], [ [['opportunity to tell the real story', 7]], '28731764', '0' ], [ [['entirely respectable way to put off the searing constitutional controversy', 7]], '28723797', '0' ], [ [['point of my campaign is that big ideas matter', 9]], '28712293', '0' ], [ [['As the standoff dragged into a second day', 7]], '28687424', '0' ], [ [['French police stepped up the search', 17]], '28667224', '0' ], [ [['Seeking to elevate his candidacy back to a general', 8]], '28660934', '0' ], [ [['The tragic story of Trayvon Martin', 4]], '28647343', '0' ], [ [['Karzai will get a chance soon to express', 8]], '28630306', '0' ], [ [['powerful storms stretching', 8]], '28493546', '0' ], [ [['basic norm that death is private', 6]], '28413590', '0' ], [ [['songwriter also saw a surge in sales for her debut album', 6]], '28413590', '1', 'Watch music videos from Whitney Houston ', 'on Yahoo! Music', 'http://music.yahoo.com' ], [ [['keyword', 99999999999999999999999]], 'videoID', '1', 'overwrite-pre-description', 'overwrite-link-string', 'overwrite-link-url' ] ]
Forum rules This forum is for OOC discussion about existing roleplays.
Please post all "Players Wanted" threads in the Roleplayers Wanted forum!
This topic is an Out Of Character part of the roleplay, ?The Number's Leage?. Anything posted here will also show up there.
Topic Tags:
Forum for completely Out of Character (OOC) discussion, based around whatever is happening In Character (IC). Discuss plans, storylines, and events; Recruit for your roleplaying game, or find a GM for your playergroup. This is the auto-generated OOC topic for the roleplay "The Number's Leage"
You may edit this first post as you see fit.
Harute
Member for 1 years
Can I resurve a a family for kappa?
Is this how time normally passes? Really slowly. In the right order. There's one thing I can't stand it's an unpunctual alien attack!
Tonks
Member for 0 years
Harute! I wanna reserve the Greek letter Beta!!!!
angel51897
Member for 0 years
Post a reply
RolePlayGateway is a site built by a couple roleplayers who wanted to give a little something back to the roleplay community. The site has no intention of earning any profit, and is paid for out of their own pockets.
If you appreciate what they do, feel free to donate your spare change to help feed them on the weekends. After selecting the amount you want to donate from the menu, you can continue by clicking on PayPal logo.
In our last home build blog, we talked about signing the building contract, and picking out some more finishes. Since then we?ve lined up insurance, had an appraisal, and finalized the construction loan. Of course, we are still trying to plan out the little details in the house, too. With everything lined up and ready to go, we can now close on the lot and start building. We?ve got a closing scheduled for this coming Monday, and the builder is just waiting for the go head. There?s even a backhoe sitting on our lot already. The builder tells us he will be scraping dirt on Tuesday, surveying on Wednesday, digging on Thursday, and starting on footings by Friday.
The big talk in the neighborhood has been ?The Rock?. Our lot had a huge rock sitting on it that the developer had just left there years ago. We talked about the possibility of keeping it because it seemed like a fun thing for kids to climb on down the road. Although, this rock took up a good chunk of yard space, and it would be nearly impossible to move out between houses later. The developer planned to get rid of it, so we told him to go head. In any case, we came to find out that the rock was kind of a congregating place for the neighborhood kids. We have several friends that live in the neighborhood and have already met a few neighbors.?It seems like every time we talk to someone in the neighborhood they ask ?what?are you going to do with the rock?? ?We kind of feel bad getting rid of a neighborhood landmark, and wondered if it could be moved to the nearby park. However, it turns out the developer has already started to smash it up in order to move it out. Hopefully the neighborhood kids will forgive us.
We are excited to get this property closed and get the construction started!
Free of charge Membership rights, Free of charge Submitting, Free of charge e-books, Free of charge Websites, Free of charge Packages, Free of charge Magazine, Able to Enroll in, indeed nearly anything Free of charge yerba mate comes with a outstanding tugging energy in the Web and Internet Marketing. It is just remarkable how this several notification term Free of charge can get the creative thinking of not only the beginners but also the most seasoned and expert Internet Marketers and Affiliate Marketers. The achievements internet Marketing or Internet Marketing Organization relies upon to the large degree on numerous inputs just like Conviction, Perseverance and Inspiration among others. Inspite of obtaining these attributes, monetary disadvantages generally is a dampening take into account your try to do well. So a suggestion of absolutely free methods, absolutely free e-books, absolutely free magazine and many others. might be just the factor you?ve been yearning for to enhance your assurance and assist you to grow into success your online business. Even if you are not in short supply of funds to operate internet or Internet Marketing corporations the offer of absolutely free things that could be important to acquire internet organization is one thing no wise online marketer wants to overlook. Why spend on one thing available to get it without cost! It is important to remember that even with the visible screen in the term Free of charge, some items are not at all times Free of charge plus some can be worthless although the urge and aspire to take them into consideration persists. Taking advantage of this a wide range of scammers who want to make a quick buck. And here , the newbie should be careful without fall prey to scammers. Lots of true wise Online marketers do employ this normal listlessness of each husband and wife and gives absolutely free what to enhance their corporations binary options trading system. There are actually of course numerous wonderful absolutely free website owner methods which are very popular with Online marketers, Affiliate marketers, Web online business internet marketers and other on the internet internet marketers. Also Free of charge e-books and Content created best regards while using lone goal of coaching the listeners are also seriously popular and popular by online marketers. There are actually web pages interacting exclusively with Free of charge products which personal loans for bad credit are extremely well-liked over the net. One more Free of charge product or service very popular with cheap business internet marketers are free of charge magazine. You can also find numerous greatly popular Able to be a part of internet programs which are traditional, safe and world-wide in nature, who supply you with absolutely free methods, absolutely free websites and a wonderful service techniques. So the web abounds with an array of absolutely free things. Some have secret costs, Some send you to swindles, Some have each paid and free versions, Some are totally free with nsa. Common outings to search engines like google just like Bing, Yahoo, Bing and Altavista and researching these several absolutely free things will help you eliminate the favorable from the Bad plus the Unsightly. Great men and women are readily available out there over the net Earth who are able to discuss their knowledge and know-how with the remainder of the Web fraternity free of charge. Site owners and Online Enterprisers will need to in truth be relieved about bat roosting People and Companies who are constantly doing the web practical experience incredibly easier, more cost-effective, nice and enjoyable for scores of Internet users. The Unbelievable Power the saying Freedom unquestionably continue to intrigue the hearts and heads in the Online Marketing and Internet Marketing community till a an increasingly strong replace is discovered. alfred driver loves riding the horse by the night arb
[unable to retrieve full-text content]March 28, 2012 | Author: joydeb daniel | Posted in Health & Fitness. Well, safety is a prime concern to everyone, so you will definitely want to use kondomer as a precaution when it comes to protect yourself from sexually transmitted diseases (or STD'S) or wanted pregnancy of your partner. Incidentally, the STD's are gaining ground all over the world fast and in the US alone, every year instances of 10-12 million of people affected by these diseases take place. In order to deal with the ...
PBX Telephone Methods can be considerably baffling for the uninitiated so this post hopes to give and insight into their workings and advice on selecting the correct tools for your business.
PBX stands for Personal Branch Exchange and illustrate a type of phone system that is created to give communications amongst telephones, fax devices, modems and other extensions inside a private business these kinds of as business premises. This superior business telephone system also has the facility to hook up to exterior manifeste telephone networks as nicely.
As engineering has progressed, so phone programs have grow to be more affordable. PBX telephone systems in certain are a common selection for firms of all sizes from little companies of below ten workers to big multi-workplace corporations. One particular of the causes for this popularity is the simplicity of extension must the telephone method need to have to be expanded.
In a nutshell, a PBX phone program is composed of an inner mobile phone network, exterior phone lines and a console for manual management. Classic PBX telephone programs use physical lines to route calls all through the office. This can be fairly costly and so the advancement of PBX systems has moved towards using web connections as the primary canal for communications. These VoIP (Voice more than Internet Protocol) PBX techniques do just as significantly as conventional PBX techniques but also supply a range of functions that occur from making use of the intenet to hook up consumers. For instance, get in touch with fees can be negligible in comparison to traditional telephone calls. Enlargement of the enterprise mobile phone program is also even less complicated. VoIP programs also mean that existing information networks can be employed as a result cutting out phone line installation fees.
Other attributes of a VoIP Phone Method include get in touch with forwarding, phone ready, convention call capability, on-keep tunes and laptop or computer telephony integration. These features can be added to the telephone program as necessary by the business.
Even though VoIP Telephone Techniques may appear the obvious decision and the way forward for PBX Communications solutions, organizations with only a single office and do not make many long length calls may possibly select a classic PBX method as the protecting made by upgrading their existing system may possibly not be as evident.
About the Creator
John Horace is a freelance internet content author covering topics like pensions, mortgages, telecommunications technology and property expense. He lives in Nottinghamshire but supports Watford FC.
Forum rules This forum is for OOC discussion about existing roleplays.
Please post all "Players Wanted" threads in the Roleplayers Wanted forum!
This topic is an Out Of Character part of the roleplay, ?I'm not Sick.?. Anything posted here will also show up there.
Topic Tags:
Forum for completely Out of Character (OOC) discussion, based around whatever is happening In Character (IC). Discuss plans, storylines, and events; Recruit for your roleplaying game, or find a GM for your playergroup. This is the auto-generated OOC topic for the roleplay "I'm not Sick."
You may edit this first post as you see fit.
There are forks in the road What will you choose How while you fight back in such ways.
Kiri711
Member for 2 years
I would like to reserve fire please. In case it's taken before i can send in my character sheet.
SukaiKori
Member for 0 years
Post a reply
RolePlayGateway is a site built by a couple roleplayers who wanted to give a little something back to the roleplay community. The site has no intention of earning any profit, and is paid for out of their own pockets.
If you appreciate what they do, feel free to donate your spare change to help feed them on the weekends. After selecting the amount you want to donate from the menu, you can continue by clicking on PayPal logo.
[unable to retrieve full-text content]Playing Games for Learning? Thought video games were just for passing time in your living room? Think again. How many of you are actually gamers or have a gamer in your house? It's almost 70%. So let's explore how we ...
GREENSBORO, N.C. (AP) ? Xavier is making a habit of reaching the round of 16.
Senior center Kenny Frease scored a career-high 25 points to go with 12 rebounds, and the Musketeers knocked off upset-minded Lehigh 70-58 Sunday night to advance to the regional semifinals of the NCAA tournament for the fourth time in five years.
Xavier was ranked as high as eighth in the country earlier this season, but a midseason bench-clearing brawl that resulted in player suspensions seemed to turn the season on a sour note. They lost their edge and had to battle to make the tournament.
But they seem to have rekindled their momentum.
"We ultimately knew we had talent, but for whatever reason things just weren't clicking," Frease said. "We're coming together at the right time. It feels real good to get back to the Sweet 16."
Lehigh, which stunned No. 2 seed Duke on Friday, was looking to become the first 15 seed to make it to the tournament's second weekend.
But the 7-foot Frease stood in the way.
He dominated in the paint, hitting 11 of 13 shots, and Tu Holloway was his normal productive self with 21 points as 10th-seeded Xavier (22-12) moved on to play No. 3 seed Baylor on Friday in the South Regional at Atlanta.
"Lehigh is a very good team, but they're also small," said Xavier coach Chris Mack. "I'm sure they don't face the type of size that Kenny presents. We just wanted to be able to get the ball to Kenny, and fortunately he was able to finish."
Frease was quick to turn the praise to his teammates after what Mack called his best game as a Musketeer.
"My guards put me in great position," Frease said. "I wouldn't have been able to score if it wasn't for those guys putting me in good positions and finding me at the right time. It made my job pretty easy. All I had to do was turn and finish."
Lehigh center Gabe Knutson, who gave up three inches and 55 pounds to Frease, said he tried the best he could to defend Xavier's burly big man.
"I didn't do as good of a job as I could have defending him, but he's a tremendous player and he had a tremendous night," Knutson said.
Lehigh's shooting, on the other hand, wasn't so tremendous ? particularly in the second half with two separate stretches in which the team didn't make a basket for more than 6 minutes.
The Mountain Hawks shot 5 of 34 (14.7 percent) from the field in the second half.
The Musketeers held C.J. McCollum, the nation's fifth-leading scorer, to 14 points on 5-of-22 shooting and overcame a 15-point first-half deficit. He came in averaging 21.9 points per game and scored 30 in the win over Duke.
"I just wasn't making shots," McCollum said. "I just missed some shots tonight, and offense is going to come and go. We still have to get stops on defense, and we didn't do that tonight."
Mackey McKnight had 20 points for Lehigh (27-7), which tied a Patriot League record for wins in a season.
The Musketeers won despite playing most of the game without their third-leading scorer, Dezmine Wells. He injured his right toe in the first half and did not return.
Mack said he will be reevaluated this week but is hopeful he can play against Baylor.
The Mountain Hawks started strong, opening a 35-20 lead behind 53 percent shooting and 14 first-half points from McKnight. But after McCollum picked up his second foul Xavier clawed back to cut the lead to 37-33 at halftime behind a 3-point buzzer-beater by Holloway.
The Mountain Hawks went more than 7 minutes without a field goal to start the second half ? missing their first 10 shots from the field ? and the Musketeers took advantage by going on a 14-3 spurt to take a 47-40 lead.
The Mountain Hawks fought back again, however, tying the game at 52. That's when Xavier took over for good, closing with an 18-6 run.
Holloway, who had to change his jersey number in the second half from 52 to 24 after getting blood on it, led the charge.
He hit a 3-pointer with 6:58 remaining to give the Musketeers a 55-52 lead they never relinquished.
He scored 15 of his 21 points in the second half. That came two nights after he scored 17 of his 25 after halftime in a win over Notre Dame.
Holloway said getting back to the round of 16 showed Xavier's resolve.
"Coach Mack was talking to us about how everyone's taking shots at us around the country," Holloway said. "After going through so much, we're still standing today in the last 16 teams. And it showed. It just shows the character."
Unprecedented academic-industry collaboration seeks new drugs and novel treatments for autism Public release date: 19-Mar-2012 [ | E-mail | Share ]
Contact: Jane RUbinstein jrubinstein@rubenstein.com 212-084-38287 Autism Speaks
Pharmaceutical companies, advocacy organizations and universities join forces to discover new drugs and assess novel treatment approaches for autism
An international consortium of scientists, led by Roche, King's College London, and Autism Speaks, is collaborating on one of the largest ever academic-industry research projects to find new methods for the development of drugs for autism spectrum disorder (ASD).
European Autism Interventions A Multicentre Study for Developing New Medications (EU-AIMS) is the largest single grant for autism research in the world and the largest for the study of any mental health disorder in Europe.
The project, which will take place over the next five years, brings together top scientists from universities around the world, experts from Autism Speaks the world's leading autism science and advocacy organization as well as major global drug companies from the European Federation of Pharmaceutical Industry Associations (EFPIA) including Roche, Eli Lilly, Servier, Janssen Pharmaceutica, Pfizer and Vifor Pharma.
Autism Spectrum Disorders (ASD) affects an estimated 1% of children worldwide and more children will be diagnosed with autism this year than with AIDS, juvenile diabetes and pediatric cancer combined. With a wealth of knowledge and research findings related to ASD emerging every year, it has been hard to take these findings from the bench to the clinic.
Robert Ring, Vice President of Translational Research for Autism Speaks said: "The lack of effective pharmacological treatments for ASD has a profound effect on patients' lives. We are excited that with this unique collaboration we may see a real shift in future treatment for this devastating disorder."
EU-AIMS will focus on three areas: the development and validation of translational research approaches for the advancement of novel therapies for ASD; the identification, alignment, and development of expert clinical sites across Europe to run clinical trials; and the creation of an interactive platform for ASD professionals and patients.
By the end of the project, EU-AIMS expects to provide novel validated cellular assays, animal models, new fMRI methods with dedicated analysis techniques, new PET radioligands, as well as new genetic and proteomic biomarkers for patient-segmentation or individual response prediction. It aims to establish a research network that can then move on to testing the investigational treatments in humans.
King's College London leads an academic partnership of 14 European centres of excellence comprising Biozentrum Universitt Basel (Switzerland), Birkbeck College, University of London (UK), Cambridge University (UK), Central Institute of Mental Health Mannheim (Germany), Commissariat l'Energie Atomique et Aux Alternatives (France), the European Molecular Biology Laboratory (Germany), Institut Pasteur (France), Institute of Education (UK), Karolinska Institute (Sweden), Max-Planck Institute of Experimental Medicine (Germany), Radboud University Nijmegen Medical Centre (The Netherlands), University "Campus Bio-Medico" (Italy), University Medical Centre (The Netherlands) and University Ulm (Germany).
Two other pharmaceutical small and medium-sized enterprises (SME): deCode Genetics (Iceland) and NeuroSearch (Denmark) will contribute to the success of EU-AIMS, while the SME GABO:mi (Germany) will be managing the project.
Professor Declan Murphy, King's College London said: "This ground-breaking integrated research effort is unprecedented and is designed to allow us to change the scientific landscape of autism research and clinical drug development throughout Europe."
Luca Santarelli, Global Head of Roche Neurosciences said: "This collaborative effort is in full alignment with Roche Neurosciences strategy which is to develop personalized treatment options for serious patient needs." Will Spooren, Project Coordinator of EU-AIMS and group leader Behavioral Pharmacology at Roche Neuroscience, added: "Recent genomic and functional studies have shed light on the pathophysiology of autism. We need to work together if we want to fully harness those developments and pave the way for new treatment options which would cluster ASD patients sharing common pathophysiological features."
The research of EU-AIMS receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n 115300, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013), from the EFPIA companies' in kind contribution and from the Autism Speaks resulting in a total of USD $38.7 million.
###
About Autism
Autism is a general term used to describe a group of complex developmental brain disorders autism spectrum disorders caused by a combination of genes and environmental influences. These disorders are characterized, in varying degrees, by social and behavioral challenges, as well as repetitive behaviors. An estimated 1% of children is on the autism spectrum a significant increase on previous figures, the reasons for which are not fully understood.
About Autism Speaks
Autism Speaks, founded in 2005 by Suzanne and Bob Wright, is the world's leading autism science and advocacy organization. Since its inception, Autism Speaks has made enormous strides, committing over $173 million to research and developing innovative resources for families. The organization is dedicated to funding research into the causes, prevention, treatments and a cure for autism; increasing awareness of autism spectrum disorders; and advocating for the needs of individuals with autism and their families. For more information, visit http://www.AutismSpeaks.org.
All trademarks used or mentioned in this release are protected by law.
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. With a 2 billion euro budget, IMI supports collaborative research projects and builds networks of industrial and academic experts in Europe that will boost innovation in healthcare. Acting as a neutral third party in creating innovative partnerships, IMI aims to build a more collaborative ecosystem for pharmaceutical research and development. IMI is a joint undertaking between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). For more information: http://www.imi.europa.eu/.
About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, headquartered in the United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: http://www.roche.com.
About King's College London
King's College London is one of the top 30 universities in the world (2011/12 QS international world rankings), and was The Sunday Times 'University of the Year 2010/11', and the fourth oldest in England. A research-led university based in the heart of London, King's has nearly 23,500 students (of whom more than 9,000 are graduate students) from nearly 140 countries, and some 6,000 employees. King's is in the second phase of a 1 billion redevelopment programme which is transforming its estate. King's has an outstanding reputation for providing world-class teaching and cutting-edge research. For more information, visit: http://www.kcl.ac.uk
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Unprecedented academic-industry collaboration seeks new drugs and novel treatments for autism Public release date: 19-Mar-2012 [ | E-mail | Share ]
Contact: Jane RUbinstein jrubinstein@rubenstein.com 212-084-38287 Autism Speaks
Pharmaceutical companies, advocacy organizations and universities join forces to discover new drugs and assess novel treatment approaches for autism
An international consortium of scientists, led by Roche, King's College London, and Autism Speaks, is collaborating on one of the largest ever academic-industry research projects to find new methods for the development of drugs for autism spectrum disorder (ASD).
European Autism Interventions A Multicentre Study for Developing New Medications (EU-AIMS) is the largest single grant for autism research in the world and the largest for the study of any mental health disorder in Europe.
The project, which will take place over the next five years, brings together top scientists from universities around the world, experts from Autism Speaks the world's leading autism science and advocacy organization as well as major global drug companies from the European Federation of Pharmaceutical Industry Associations (EFPIA) including Roche, Eli Lilly, Servier, Janssen Pharmaceutica, Pfizer and Vifor Pharma.
Autism Spectrum Disorders (ASD) affects an estimated 1% of children worldwide and more children will be diagnosed with autism this year than with AIDS, juvenile diabetes and pediatric cancer combined. With a wealth of knowledge and research findings related to ASD emerging every year, it has been hard to take these findings from the bench to the clinic.
Robert Ring, Vice President of Translational Research for Autism Speaks said: "The lack of effective pharmacological treatments for ASD has a profound effect on patients' lives. We are excited that with this unique collaboration we may see a real shift in future treatment for this devastating disorder."
EU-AIMS will focus on three areas: the development and validation of translational research approaches for the advancement of novel therapies for ASD; the identification, alignment, and development of expert clinical sites across Europe to run clinical trials; and the creation of an interactive platform for ASD professionals and patients.
By the end of the project, EU-AIMS expects to provide novel validated cellular assays, animal models, new fMRI methods with dedicated analysis techniques, new PET radioligands, as well as new genetic and proteomic biomarkers for patient-segmentation or individual response prediction. It aims to establish a research network that can then move on to testing the investigational treatments in humans.
King's College London leads an academic partnership of 14 European centres of excellence comprising Biozentrum Universitt Basel (Switzerland), Birkbeck College, University of London (UK), Cambridge University (UK), Central Institute of Mental Health Mannheim (Germany), Commissariat l'Energie Atomique et Aux Alternatives (France), the European Molecular Biology Laboratory (Germany), Institut Pasteur (France), Institute of Education (UK), Karolinska Institute (Sweden), Max-Planck Institute of Experimental Medicine (Germany), Radboud University Nijmegen Medical Centre (The Netherlands), University "Campus Bio-Medico" (Italy), University Medical Centre (The Netherlands) and University Ulm (Germany).
Two other pharmaceutical small and medium-sized enterprises (SME): deCode Genetics (Iceland) and NeuroSearch (Denmark) will contribute to the success of EU-AIMS, while the SME GABO:mi (Germany) will be managing the project.
Professor Declan Murphy, King's College London said: "This ground-breaking integrated research effort is unprecedented and is designed to allow us to change the scientific landscape of autism research and clinical drug development throughout Europe."
Luca Santarelli, Global Head of Roche Neurosciences said: "This collaborative effort is in full alignment with Roche Neurosciences strategy which is to develop personalized treatment options for serious patient needs." Will Spooren, Project Coordinator of EU-AIMS and group leader Behavioral Pharmacology at Roche Neuroscience, added: "Recent genomic and functional studies have shed light on the pathophysiology of autism. We need to work together if we want to fully harness those developments and pave the way for new treatment options which would cluster ASD patients sharing common pathophysiological features."
The research of EU-AIMS receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n 115300, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013), from the EFPIA companies' in kind contribution and from the Autism Speaks resulting in a total of USD $38.7 million.
###
About Autism
Autism is a general term used to describe a group of complex developmental brain disorders autism spectrum disorders caused by a combination of genes and environmental influences. These disorders are characterized, in varying degrees, by social and behavioral challenges, as well as repetitive behaviors. An estimated 1% of children is on the autism spectrum a significant increase on previous figures, the reasons for which are not fully understood.
About Autism Speaks
Autism Speaks, founded in 2005 by Suzanne and Bob Wright, is the world's leading autism science and advocacy organization. Since its inception, Autism Speaks has made enormous strides, committing over $173 million to research and developing innovative resources for families. The organization is dedicated to funding research into the causes, prevention, treatments and a cure for autism; increasing awareness of autism spectrum disorders; and advocating for the needs of individuals with autism and their families. For more information, visit http://www.AutismSpeaks.org.
All trademarks used or mentioned in this release are protected by law.
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. With a 2 billion euro budget, IMI supports collaborative research projects and builds networks of industrial and academic experts in Europe that will boost innovation in healthcare. Acting as a neutral third party in creating innovative partnerships, IMI aims to build a more collaborative ecosystem for pharmaceutical research and development. IMI is a joint undertaking between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). For more information: http://www.imi.europa.eu/.
About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, headquartered in the United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: http://www.roche.com.
About King's College London
King's College London is one of the top 30 universities in the world (2011/12 QS international world rankings), and was The Sunday Times 'University of the Year 2010/11', and the fourth oldest in England. A research-led university based in the heart of London, King's has nearly 23,500 students (of whom more than 9,000 are graduate students) from nearly 140 countries, and some 6,000 employees. King's is in the second phase of a 1 billion redevelopment programme which is transforming its estate. King's has an outstanding reputation for providing world-class teaching and cutting-edge research. For more information, visit: http://www.kcl.ac.uk
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Are looking to buy a luxury estate, home, condominium, townhouse or investment property in the Westwood, Wilshire Corridor, Little Holmby & Century City areas of Los Angeles, California 90024 & 90067?
Let us help you find everything you need to know about buying or selling a home! As one of the preeminent, professional real estate teams in my community for over 21 years, we are dedicated to providing the finest service available while breaking new ground.
Because the real estate industry is becoming more sophisticated and challenging every day, you need a professional that understands the industry and is positioned to stay ahead of the game.
We go the extra mile to help you achieve your goals. That?s why we constantly research the market and property values so your home is priced effectively from day one. We also make sure the public knows your home is for sale by using innovative advertising and marketing techniques to attract potential buyers.
The Christophe Choo Real Estate Group at Coldwell?Banker Previews International is the most comprehensive online source for luxury real estate listings, from estate homes to luxury condominiums, incredible tear down opportunities and investment properties. Based in beautiful Beverly Hills, California 90210, the Christophe Choo Real Estate Group provides exclusive luxury homes for sale on a local, global and international stage. Hence the tagline: ?Locally Known ? Globally Connected?. Search for luxury properties in your area, whether in the ?Platinum Triangle? areas of the Westside of Los Angeles of Beverly Hills, Holmby?Hills and Bel Air or in The Sunset Strip, Hollywood Hills, Brentwood, Westwood, the Wilshire Corridor, Century City, Pacific Palisades, Santa Monica, Malibu, Venice, Marina Del Rey, Cheviot Hills, Hancock Park, Los Feliz and the key Westside areas of Los Angeles, the Christophe Choo Real Estate Group can help.
Call or email me today! Christophe Choo The Christophe Choo Real Estate Group Coldwell Banker Previews International Beverly Hills 310-777-6342 Or send me an email: Christophe@ChristopheChoo.com www.ChristopheChoo.com
Showing properties
1 - 50 of 356.
See more Westwood - Century City community real estate.
(all data current as of
3/18/2012)
4 beds, 7.0 baths
Home size: 7,976 sq ft
Year built: 2011
Days on market: 165
Walk Score?: 65
3 beds, 4.5 baths
Home size: 5,306 sq ft
Year built: 2010
Parking spots: 2
Days on market: 180
Walk Score?: 80
4 beds, 4.5 baths
Home size: 6,480 sq ft
Year built: 2006
Parking spots: 4
Days on market: 265
Walk Score?: 88
3 beds, 4.5 baths
Home size: 5,290 sq ft
Year built: 2001
Parking spots: 3
Days on market: 697
Walk Score?: 82
4 beds, 5.5 baths
Home size: 4,497 sq ft
Year built: 2010
Days on market: 640
Walk Score?: 80
3 beds, 4.5 baths
Home size: 3,535 sq ft
Year built: 2009
Parking spots: 2
Days on market: 68
Walk Score?: 86
2 beds, 2.5 baths
Home size: 4,158 sq ft
Year built: 2011
Days on market: 340
Walk Score?: 65
2 beds, 3.5 baths
Home size: 4,158 sq ft
Year built: 2011
Days on market: 165
Walk Score?: 65
3 beds, 4.5 baths
Home size: 3,446 sq ft
Year built: 2010
Days on market: 180
Walk Score?: 80
2 beds, 3.5 baths
Home size: 4,158 sq ft
Year built: 2011
Days on market: 166
Walk Score?: 65
3 beds, 4.5 baths
Home size: 3,446 sq ft
Year built: 2010
Days on market: 207
Walk Score?: 80
3 beds, 3.5 baths
Home size: 3,813 sq ft
Year built: 2011
Days on market: 165
Walk Score?: 65
4 beds, 5.5 baths
Home size: 4,642 sq ft
Year built: 2010
Days on market: 640
Walk Score?: 80
3 beds, 3.5 baths
Home size: 3,585 sq ft
Year built: 2010
Days on market: 640
Walk Score?: 80
3 beds, 3.5 baths
Home size: 3,813 sq ft
Year built: 2011
Days on market: 165
Walk Score?: 65
6 beds, 7.5 baths
Home size: 5,533 sq ft
Lot size: 16,944 sq ft
Year built: 1938
Days on market: 69
Walk Score?: 57
2 beds, 3.5 baths
Home size: 3,455 sq ft
Year built: 2010
Days on market: 95
Walk Score?: 80
2 beds, 3.5 baths
Home size: 3,455 sq ft
Year built: 2010
Days on market: 95
Walk Score?: 80
4 beds, 5 full, 1 part baths
Home size: 5,957 sq ft
Year built: 1989
Parking spots: 8
Days on market: 225
Walk Score?: 69
3 beds, 3.5 baths
Home size: 3,813 sq ft
Year built: 2011
Days on market: 166
Walk Score?: 65
3 beds, 4.5 baths
Home size: 3,470 sq ft
Year built: 2010
Days on market: 640
Walk Score?: 80
5 beds, 5 full, 1 part baths
Home size: 4,938 sq ft
Lot size: 16,180 sq ft
Year built: 1939
Parking spots: 4
Days on market: 56
Walk Score?: 57
3 beds, 3 full, 1 part baths
Home size: 3,364 sq ft
Year built: 2005
Parking spots: 6
Days on market: 33
Walk Score?: 88
3 beds, 4.5 baths
Home size: 3,500 sq ft
Year built: 2009
Parking spots: 2
Days on market: 38
Walk Score?: 86
3 beds, 3.5 baths
Home size: 3,237 sq ft
Year built: 2010
Days on market: 180
Walk Score?: 80
3 beds, 3.5 baths
Home size: 3,237 sq ft
Year built: 2010
Days on market: 467
Walk Score?: 80
3 beds, 4.5 baths
Home size: 3,535 sq ft
Year built: 2009
Parking spots: 2
Days on market: 75
Walk Score?: 86
3 beds, 3 full, 1 part baths
Home size: 3,499 sq ft
Year built: 1989
Parking spots: 2
Days on market: 12
Walk Score?: 71
2 beds, 2.5 baths
Home size: 3,404 sq ft
Year built: 2010
Days on market: 180
Walk Score?: 80
2 beds, 2.5 baths
Home size: 3,404 sq ft
Year built: 2010
Days on market: 96
Walk Score?: 80
2 beds, 2.5 baths
Home size: 3,404 sq ft
Year built: 2010
Parking spots: 2
Days on market: 207
Walk Score?: 80
4 beds, 3 full, 1 part baths
Home size: 3,552 sq ft
Lot size: 12,770 sq ft
Year built: 1926
Parking spots: 2
Days on market: 11
Walk Score?: 77
4 beds, 4 full, 1 part baths
Home size: 5,383 sq ft
Year built: 1980
Parking spots: 6
Days on market: 75
Walk Score?: 74
3 beds, 4.5 baths
Home size: 3,535 sq ft
Year built: 2009
Parking spots: 2
Days on market: 68
Walk Score?: 86
4 beds, 4.0 baths
Home size: 4,248 sq ft
Lot size: 11,620 sq ft
Year built: 1935
Parking spots: 2
Days on market: 40
Walk Score?: 49
2 beds, 2.5 baths
Home size: 2,280 sq ft
Year built: 2010
Days on market: 96
Walk Score?: 80
2 beds, 2 full, 1 part baths
Home size: 2,640 sq ft
Lot size: 1.06 ac
Year built: 2005
Parking spots: 4
Days on market: 130
Walk Score?: 88
4 beds, 4.5 baths
Home size: 3,520 sq ft
Lot size: 7,187 sq ft
Year built: 1988
Days on market: 47
Walk Score?: 66
3 beds, 3.5 baths
Home size: 2,368 sq ft
Year built: 1982
Parking spots: 2
Days on market: 162
Walk Score?: 74
3 beds, 4.0 baths
Home size: 2,625 sq ft
Lot size: 14,418 sq ft
Year built: 1950
Parking spots: 2
Days on market: 35
Walk Score?: 55
4 beds, 3.5 baths
Home size: 3,153 sq ft
Lot size: 9,626 sq ft
Year built: 1936
Parking spots: 2
Days on market: 47
Walk Score?: 60
2 beds, 3.0 baths
Home size: 2,640 sq ft
Year built: 2005
Days on market: 238
Walk Score?: 88
2 beds, 2.5 baths
Home size: 2,520 sq ft
Year built: 2010
Days on market: 96
Walk Score?: 80
2 beds, 2.5 baths
Home size: 3,190 sq ft
Year built: 1990
Parking spots: 2
Days on market: 13
Walk Score?: 63
3 beds, 3.0 baths
Home size: 2,776 sq ft
Year built: 1989
Days on market: 18
Walk Score?: 71
3 beds, 3.5 baths
Home size: 3,270 sq ft
Year built: 2006
Parking spots: 2
Days on market: 714
Walk Score?: 88
2 beds, 2.5 baths
Year built: 2010
Days on market: 227
Walk Score?: 80
7 beds, 6.0 baths
Home size: 4,882 sq ft
Lot size: 11,704 sq ft
Year built: 1950
Days on market: 48
Walk Score?: 54
2 beds, 2.5 baths
Home size: 3,000 sq ft
Year built: 1982
Days on market: 120
Walk Score?: 74
3 beds, 3.5 baths
Home size: 3,143 sq ft
Year built: 1990
Parking spots: 2
Days on market: 899
Walk Score?: 63
Listing information deemed reliable but not guaranteed. Read full disclaimer.
Say what you will about the benefits of clean energy or the costs of pollution, the jury has returned an ambiguous verdict on the greening of the commercial real-estate market.? The niche has become mainstream. ?Anyone who says green buildings, which are certified by third-party verifiers as demonstrating superior environmental performance and resource efficiency, are ?boutique? has not been paying attention.
With everything lined up and ready to go, we can now close on the lot and start building. We?ve got a closing scheduled for this coming Monday, and the builder is just waiting for the go head. There?s even a backhoe sitting on our lot already. The builder tells us he will be scraping dirt on Tuesday, surveying on Wednesday, digging on Thursday, and starting on footings by Friday.
that the rock was kind of a congregating place for the neighborhood kids. We have several friends that live in the neighborhood and have already met a few neighbors.?It seems like every time we talk to someone in the neighborhood they ask ?what?are you going to do with the rock?? ?We kind of feel bad getting rid of a neighborhood landmark, and wondered if it could be moved to the nearby park. However, it turns out the developer has already started to smash it up in order to move it out. Hopefully the neighborhood kids will forgive us.
![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 19-Mar-2012
Share ] 
